Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2006;332:1454 (17 June), doi:10.1136/bmj.332.7555.1454
| The first 150 words of the full text of this article appear below. |
EDITORTrinder et al suggest that expectant management may be particularly appropriate for cases of incomplete miscarriage and as an alternative management in early fetal death.1 One possible cause of first trimester miscarriage is hydatidiform molar pregnancy, which is associated with a significantly increased risk of subsequent development of persistent gestational trophoblastic disease.
Only around 40% of hydatidiform moles are detected as molar on pre-evacuation ultrasound examination, most appearing to be incomplete or missed miscarriages by sonography alone.2 Furthermore, after termination of pregnancy patients presenting with symptomatic persistent gestational trophoblastic disease, compared with those who have the diagnosis made histologically after evacuation, are significantly more likely to experience life threatening complications and to require additional surgical or chemotherapeutic interventions.3
Routine histopathological examination of evacuated products of conception after failure of early pregnancy remains the gold standard for detecting molar pregnancy. The proportion of cases in whom tissue is submitted
Neil J Sebire, consultant in trophoblastic disease pathology
Trophoblastic Disease Unit, Charing Cross Hospital, London WC1N 3JH sebirn@gosh.nhs.uk